Accordingly, in this study we developed novel HSV-1 based oncolytic viruses targeting mesothelin, a TAA frequently expressed in triple-negative breast cancer, as well as in additional neoplasms, including the orphan disease mesothelioma. This evidence concerns the gene MSLN and mesothelioma.